CLINICAL AND EPIDEMIOLOGICAL ANALYSIS OF DISEASE SPECIFIC HYPERTENSIVE OF PREGNANCY

Specific Hypertension Disease in pregnancy (HDP) is a syndrome that happens at the end of the 2nd trimester of pregnancy, characterized by hypertension and proteinuria. It is estimated that in developed countries, preeclampsia occurs in 6% of pregnant women, as this rate is two to three times higher...

Descripción completa

Detalles Bibliográficos
Autores: Cozendey, Aline Guedes, da Silva Nogueira, Carla Vanessa Pereira, Rangel, Carolina Cassiano, Bravin, Débora Moreira, Vieira, Edwiges Brambila, Alecrin, Israel Nunes
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:Brasil
Institución:Faculdade de Medicina de Campos (FMC)
Repositorio:Revista Científica da Faculdade de Medicina de Campos
Idioma:portugués
OAI Identifier:oai:ojs.www.fmc.br:article/26
Acceso en línea:https://www.fmc.br/ojs/index.php/RCFMC/article/view/26
Access Level:acceso abierto
Palabra clave:DHEG
gestantes
hipertensão
preeclampsia
pregnant women
hypertension
Descripción
Sumario:Specific Hypertension Disease in pregnancy (HDP) is a syndrome that happens at the end of the 2nd trimester of pregnancy, characterized by hypertension and proteinuria. It is estimated that in developed countries, preeclampsia occurs in 6% of pregnant women, as this rate is two to three times higher in developing countries. It presents itself as a major public health problems due to their high rates of morbidity and maternal and perinatal mortality. OBJECTIVES: To analyze the clinical and epidemiological aspects of Pregnancy Specific Hypertension Disease. METHODS: This study by the Cane Planters Hospital (HPC), a regional reference hospital for high-risk pregnancy, in Campos, RJ. 1798 records were studied, pertaining to all pregnant women assisted by the obstetrics service from October 2012 to March 2013. Data collection was designed a form. RESULTS: The prevalence of preeclampsia was 18.24%. Sample 1798 met in service, 40.2% were aged 26-34 years; 41.8% were first pregnancy, these, 8.53% had hypertensive crisis and 2.13%, eclampsia, as major complications. Fetal complications amounted to 8.53% (28/328), and 2.43% (8/328) was due to intra uterine death and 3.96% (13/328) of prematurity. 71.6% of pregnant women had the admission resolution cesarean delivery. CONCLUSIONS: The prevalence of preeclampsia was 18.24%. It is essential to stress the importance of conducting proper treatment and monitoring of pregnant women with preeclampsia, seeking thereby reduce maternal and fetal complications and intrauterine deaths.